Skip to main content
MCK logo

McKesson Corporation

MCKNYSEHealthcareMedical Distribution

$1,012.34Today:- (-)1Y +27.66%

As of Oct 22, 2026 close

Market cap
$120.67B
P/E (TTM)
26.28
Forward P/E
18.61
Dividend yield
0.34%
52-week range
$723.68$1,030.27
Volume (live)
-
Avg. volume (3M)
763.96K

McKesson (MCK) Stock Price & Financial Analysis

McKesson Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$1,006.07 - $1,025.62
52-Week High$1,030.27
52-Week Low$723.68
Open$1,025.62
Volume (last close)629.45K
Average Volume (3M)763.96K
Earnings & Profitability
Revenue (TTM)410.98B
Net Income (TTM)4.59B
Free Cash Flow (TTM)6.18B
EPS (TTM)$37.49
Profit Margin1.12%
Operating Margin1.60%
Dividend Information
Annual Dividend$3.40
Dividend Yield0.34%
Payout Ratio9.07%
Next Dividend Ex-DateDec 1, 2026
Size & Valuation
Market Cap120.67B
Shares Outstanding119.20M
P/E Ratio (TTM)26.28
Forward P/E18.61
Price to Sales (P/S)0.29
Price to Book (P/B)-28.46
EV/EBITDA17.93
Technical Indicators
50-Day MA$902.25
200-Day MA$855.96
1-Year Change+27.66%

Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology

Compare MCK with other stocks

McKesson at a Glance

As of the Oct 22, 2026 close, McKesson (MCK) has a market capitalization of $120.67B. The stock trades at 26.3× trailing earnings, 18.6× forward earnings and 0.3× sales. Over the trailing twelve months it earned $4.59B on revenue of $410.98B (a 1.1% profit margin) and generated $6.18B of free cash flow. Revenue grew 8.8% year over year.

As of its latest reported balance sheet, it holds $5.16B in cash and securities against $11.70B of debt, a net debt position of $6.54B.

McKesson pays a quarterly dividend totaling $3.40 per share a year, a 0.34% yield at the Oct 22, 2026 close, with a 9% payout ratio and 16 consecutive years of dividend increases.

The share price is up 27.7% over the past year. At $1012.34 (the Oct 22, 2026 close) it sits near the top of its 52-week range of $723.68 to $1030.27, above its 200-day moving average of $855.96.

Based on 17 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $996.86, 1.5% below the Oct 22, 2026 close.

Frequently Asked Questions About McKesson

What is the current stock price for MCK?

As of the Oct 22, 2026 close, MCK stock trades at $1012.34. The 52-week range is $723.68–$1,030.27, with a day range of $1006.07–$1025.62.

What is the P/E ratio for MCK?

As of the Oct 22, 2026 close, McKesson's trailing twelve-month (TTM) P/E ratio is 26.3, meaning investors pay $26.3 for every $1 of annual earnings. The forward P/E is 18.6, reflecting analyst expectations for future earnings. McKesson operates in the Healthcare sector.

Does MCK pay dividends?

Yes, McKesson pays a 0.34% annual dividend yield as of the Oct 22, 2026 close ($3.40 per share a year). The trailing twelve-month payout ratio is 9.1%. The next ex-dividend date is December 1, 2026.

What do analysts recommend for MCK?

Based on ratings from 17 professional analysts over the last 90 days, the consensus for MCK is Buy. The average 12-month price target is $996.86, a 1.5% downside from the Oct 22, 2026 close of $1012.34.

What is the market cap of MCK?

As of the Oct 22, 2026 close, McKesson's market capitalization is $120.67B, classifying it as a large-cap company. McKesson operates in the Healthcare sector within the Medical Distribution industry.